Metastatic Mediastinal Germ-Cell Tumor and Concurrent COVID-19: When Chemotherapy Is Not Deferrable
- PMID: 33345433
- PMCID: PMC7873312
- DOI: 10.1002/onco.13647
Metastatic Mediastinal Germ-Cell Tumor and Concurrent COVID-19: When Chemotherapy Is Not Deferrable
Abstract
This letter to the editor describes the case of a patient with mediastinal germ cell tumor who developed COVID‐19 at the end of the first cycle of chemotherapy and continues the discussion on whether it is best to continue or delay administration of chemotherapy with an active COVID‐19 infection.
Figures
Comment in
-
In Reply.Oncologist. 2021 Feb;26(2):e350. doi: 10.1002/onco.13651. Epub 2021 Jan 9. Oncologist. 2021. PMID: 33350011 Free PMC article.
Comment on
-
Management of Germ Cell Tumors During the Outbreak of the Novel Coronavirus Disease-19 Pandemic: A Survey of International Expertise Centers.Oncologist. 2020 Oct;25(10):e1509-e1515. doi: 10.1634/theoncologist.2020-0420. Epub 2020 Sep 18. Oncologist. 2020. PMID: 32735386 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
